Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
PSQ Holdings CFO Rinn sells $18,193 in stockPSQ Holdings CSO Sells $25,096 in SharesReal price of Pugacheva's grandson's mansion revealedPSQ Holdings CFO sells $6,575 in stockWarby Parker director sells $715k in sharesFTC Probes Arm Holdings Over LicensingFlex director sells $437,640 in sharesArteris VP and CFO sells $7.38m in sharesHidden cause of hair loss: wet combingNatera co-founder sells $959,450 in stockPSQ Holdings CFO Rinn sells $18,193 in stockPSQ Holdings CSO Sells $25,096 in SharesReal price of Pugacheva's grandson's mansion revealedPSQ Holdings CFO sells $6,575 in stockWarby Parker director sells $715k in sharesFTC Probes Arm Holdings Over LicensingFlex director sells $437,640 in sharesArteris VP and CFO sells $7.38m in sharesHidden cause of hair loss: wet combingNatera co-founder sells $959,450 in stock
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#melanoma

Latest news and interesting information about melanoma.

Regeneron melanoma drug trial misses primary endpoint
Today / 00:33
|
336

Regeneron melanoma drug trial misses primary endpoint

Regeneron's melanoma drug trial fails primary endpoint: fianlimab+cemiplimab combination did not significantly improve progression-free survival vs pembrolizumab.

COMPANY →
0
...